Medication info

Magnesium Sulfate Hydrate Injection

Prescription medicationInjectionsIntramuscular injection · Intravenous injection
Ingredient · strength
Magnesium Sulfate Hydrate›100mg / 1mL
Manufacturer / importer
Daewon Pharmaceutical Co., Ltd.
Appearance
A clear, colorless liquid in a clear, colorless plastic injection.
Packaging
20mL/ampule (PE) X 50
Approval status
Active

MFDS item code 195800020 · Notified 1958.12.08 · Insurance code 671801531

Summary

Main use
Correction of hypomagnesemia; suppression of convulsions (hypomagnesemic convulsions and eclampsia); prevention of uterine rigidity
Who receives it
Adults · Children
Adult administration
○ Convulsions due to hypomagnesemia: Inject 1 ∼ 2 g of magnesium sulfate intravenously (4.05 ∼ 8.1 mmol). ○ Seizures associated with eclampsia: Inject 4 ∼ 5 g of this medication intravenously over 10 minutes (16.2 ∼ 20.25 mmol) ○ Prevention of uterine rigidity: Inject an initial dose of 4 g of this medication intravenously (16.2 mmol). Thereafter, 1 g may be administered. ○ Electrolyte replacement (hypomagnesemia): Inject 1 g of this medication intramuscularly every 6 hours for 4 doses. Alternatively, 5 g of this medication may be added to 5 % glucose injection solution or 0.9 % normal saline injection solution and administered intravenously over 3 hours. During treatment of deficiency, monitor the patient's renal excretory function closely.
Child administration
○ Children: The safety of this medication has not been studied.

Ingredients

Manufacturer
Daewon Pharmaceutical Co., Ltd.

Efficacy & effects

Correction of hypomagnesemia; suppression of convulsions (hypomagnesemic convulsions and eclampsia); prevention of uterine rigidity

  • Seizures due to hypomagnesemia
  • seizures of eclampsia
  • uterine hypertonicity
View approved original text

This medication is used to prevent and treat seizures due to hypomagnesemia and eclampsia. It also helps to prevent uterine hypertonicity, aiding in the appropriate relaxation of the uterus during childbirth. It is effective for patients with hypomagnesemia who require electrolyte replenishment. In summary, this drug is used for the prevention of seizures and convulsions, prevention of uterine hypertonicity, and improvement of electrolyte imbalance.

How it is given

Adult administration

○ Convulsions due to hypomagnesemia: Inject 1 ∼ 2 g of magnesium sulfate intravenously (4.05 ∼ 8.1 mmol). ○ Seizures associated with eclampsia: Inject 4 ∼ 5 g of this medication intravenously over 10 minutes (16.2 ∼ 20.25 mmol) ○ Prevention of uterine rigidity: Inject an initial dose of 4 g of this medication intravenously (16.2 mmol). Thereafter, 1 g may be administered. ○ Electrolyte replacement (hypomagnesemia): Inject 1 g of this medication intramuscularly every 6 hours for 4 doses. Alternatively, 5 g of this medication may be added to 5 % glucose injection solution or 0.9 % normal saline injection solution and administered intravenously over 3 hours. During treatment of deficiency, monitor the patient's renal excretory function closely.

Child administration

○ Children: The safety of this medication has not been studied.

Precautions

This drug is in a glass ampule form, so glass shards may mix when cutting the container, and care should be taken when severing the container. Special caution should be exercised when used in children and the elderly. This drug should not be used in patients with poor kidney function, those in a coma, patients with elevated blood magnesium levels, patients with cardiac conduction disorders, and myasthenia gravis patients. It should be administered cautiously to children infected with intestinal parasites or patients with heart diseases. Side effects related to the digestive system, such as vomiting or dry mouth, may occur with this medication. Rarely, bradycardia or conduction disturbances may occur, and if administered too quickly, skin flushing or vascular dilation may be observed. Additionally, symptoms of the autonomic nervous system such as headache, heaviness in the head, tremors, and paresthesia may appear. Administration of large amounts may lead to magnesium toxicity, which can result in symptoms such as warmth, thirst, low blood pressure, central nervous system depression, decreased heart rate, and respiratory paralysis, requiring immediate appropriate treatment. Caution is necessary when used with other medications that may enhance central nervous system depression. Co-administration with certain antibiotics or iron supplements may reduce the absorption of these drugs. During pregnancy, it may be used for the treatment of eclampsia, but continuous monitoring of the fetus is necessary due to potential effects such as reduced muscle tone, diminished reflexes, and hypotension. During delivery, there is a risk of respiratory depression in the newborn, and long-term use may raise concerns about potential skeletal side effects in the fetus. Lactating women should avoid administration unless under special circumstances, as the safety of this drug has not been established. Elderly patients may have reduced physical function, so care should be taken by slowing the administration rate and reducing the dosage as needed. Severe side effects may occur in case of overdose, requiring discontinuation of the drug, and if necessary, intravenous administration of calcium as an antidote for treatment. This drug should be slowly injected at a concentration of less than 10% for intravenous administration, and caution is required as precipitate may form when mixed with other medications. Additionally, to prevent infections, the skin and instruments should be disinfected before administration, and the medication should be used immediately after opening, with any remaining drug not to be reused.

Side effects

  • vomiting
  • dry mouth
  • conduction disorders
  • bradycardia
  • flushing
  • peripheral vasodilation
  • headache
  • heaviness in the head
  • trembling
  • tingling
Show 7 more
  • sensation of heat
  • thirst
  • hypotension
  • central nervous system depression
  • heart rate suppression
  • respiratory paralysis
  • sensation of heat at the injection site

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to avoid exposure to air and should be kept at room temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain the drug's efficacy and safety.

Appearance and packaging

Appearance

A clear, colorless liquid in a clear, colorless plastic injection.

Package unit

20mL/ampule (PE) X 50

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.